These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36550698)

  • 1. Arsenic-induced toxicity and the ameliorative role of antioxidants and natural compounds.
    Shiek SS; Sajai ST; Dsouza HS
    J Biochem Mol Toxicol; 2023 Mar; 37(3):e23281. PubMed ID: 36550698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: a review.
    Flora SJ; Bhadauria S; Kannan GM; Singh N
    J Environ Biol; 2007 Apr; 28(2 Suppl):333-47. PubMed ID: 17929749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning.
    Kalia K; Flora SJ
    J Occup Health; 2005 Jan; 47(1):1-21. PubMed ID: 15703449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity.
    Patrick L
    Altern Med Rev; 2003 May; 8(2):106-28. PubMed ID: 12777158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ; Flora G; Saxena G; Mishra M
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Dietary Compounds in the Treatment of Arsenic Toxicity.
    Bjørklund G; Rahaman MS; Shanaida M; Lysiuk R; Oliynyk P; Lenchyk L; Chirumbolo S; Chasapis CT; Peana M
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic Toxicity: Molecular Targets and Therapeutic Agents.
    Nurchi VM; Djordjevic AB; Crisponi G; Alexander J; Bjørklund G; Aaseth J
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033229
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
    Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
    Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counteracting arsenic toxicity: Curcumin to the rescue?
    Bahrami A; Sathyapalan T; Moallem SA; Sahebkar A
    J Hazard Mater; 2020 Dec; 400():123160. PubMed ID: 32574880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats.
    Flora SJ; Bhadauria S; Pant SC; Dhaked RK
    Life Sci; 2005 Sep; 77(18):2324-37. PubMed ID: 15964026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids and stilbenoids as a promising arsenal for the management of chronic arsenic toxicity.
    Mishra A; Oliinyk P; Lysiuk R; Lenchyk L; Rathod SSS; Antonyak H; Darmohray R; Dub N; Antoniv O; Tsal O; Upyr T
    Environ Toxicol Pharmacol; 2022 Oct; 95():103970. PubMed ID: 36067934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic arsenic toxicity in Bangladesh and West Bengal, India--a review and commentary.
    Rahman MM; Chowdhury UK; Mukherjee SC; Mondal BK; Paul K; Lodh D; Biswas BK; Chanda CR; Basu GK; Saha KC; Roy S; Das R; Palit SK; Quamruzzaman Q; Chakraborti D
    J Toxicol Clin Toxicol; 2001; 39(7):683-700. PubMed ID: 11778666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic intoxication: general aspects and chelating agents.
    Bjørklund G; Oliinyk P; Lysiuk R; Rahaman MS; Antonyak H; Lozynska I; Lenchyk L; Peana M
    Arch Toxicol; 2020 Jun; 94(6):1879-1897. PubMed ID: 32388818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic in the environment: effects on human health and possible prevention.
    Singh N; Kumar D; Sahu AP
    J Environ Biol; 2007 Apr; 28(2 Suppl):359-65. PubMed ID: 17929751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic-mediated activation of the Nrf2-Keap1 antioxidant pathway.
    Lau A; Whitman SA; Jaramillo MC; Zhang DD
    J Biochem Mol Toxicol; 2013 Feb; 27(2):99-105. PubMed ID: 23188707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry, Pharmacology, and Toxicology of Monoisoamyl Dimercaptosuccinic Acid: A Chelating Agent for Chronic Metal Poisoning.
    Flora SJS; Jain K; Panghal A; Patwa J
    Chem Res Toxicol; 2022 Oct; 35(10):1701-1719. PubMed ID: 35972774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental arsenic exposure and its contribution to human diseases, toxicity mechanism and management.
    Rahaman MS; Rahman MM; Mise N; Sikder MT; Ichihara G; Uddin MK; Kurasaki M; Ichihara S
    Environ Pollut; 2021 Nov; 289():117940. PubMed ID: 34426183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans.
    Rahman MM; Ng JC; Naidu R
    Environ Geochem Health; 2009 Apr; 31 Suppl 1():189-200. PubMed ID: 19190988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin: a pleiotropic hormone as a novel potent therapeutic candidate in arsenic toxicity.
    Abdollahzade N; Majidinia M; Babri S
    Mol Biol Rep; 2021 Sep; 48(9):6603-6618. PubMed ID: 34453671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal toxicity and natural antidotes: prevention is better than cure.
    Rajak C; Singh N; Parashar P
    Environ Sci Pollut Res Int; 2020 Dec; 27(35):43582-43598. PubMed ID: 32951168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.